Kongens Lyngby, Denmark

Qi Wang

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Danmarks Tekniske Universitet. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qi Wang. Retrieved from https://idiyas.com/inventor/qi-wang-0xnego5w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qi Wang - Innovator in Microbial Cell Catalysts

Introduction

Qi Wang is a notable inventor based in Kongens Lyngby, Denmark. He has made significant contributions to the field of microbial cell catalysts, showcasing his innovative spirit and dedication to advancing technology.

Latest Patents

Qi Wang holds a patent for "Nisin-Permeabilized Microbial Cell Catalysts." This invention highlights his expertise in utilizing microbial cells for various applications, demonstrating his commitment to innovation in biotechnology.

Career Highlights

Qi Wang is affiliated with Danmarks Tekniske Universitet, where he continues to engage in research and development. His work at this esteemed institution allows him to collaborate with other experts in the field and contribute to groundbreaking advancements.

Collaborations

Some of his notable coworkers include Peter Ruhdal Jensen and Christian Solem. Their collaborative efforts enhance the research environment and foster innovation within their projects.

Conclusion

Qi Wang's contributions to microbial cell catalysts exemplify his role as an inventor dedicated to advancing technology. His work continues to inspire future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…